• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Signal Transduct Target Ther . A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication

tetano

Editor, Senior Moderator
Signal Transduct Target Ther


. 2024 Jun 28;9(1):159.
doi: 10.1038/s41392-024-01874-5. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication

Yuzheng Zhou[SUP] #[/SUP][SUP] 1 2 [/SUP], Zongpeng Chen[SUP] #[/SUP][SUP] 1 [/SUP], Sijie Liu[SUP] 1 [/SUP], Sixu Liu[SUP] 1 [/SUP], Yujie Liao[SUP] 1 [/SUP], Ashuai Du[SUP] 1 [/SUP], Zijun Dong[SUP] 3 [/SUP], Yongxing Zhang[SUP] 1 [/SUP], Xuan Chen[SUP] 1 [/SUP], Siyi Tao[SUP] 1 [/SUP], Xin Wu[SUP] 4 [/SUP], Aroona Razzaq[SUP] 1 [/SUP], Gang Xu[SUP] 5 [/SUP], De-An Tan[SUP] 6 [/SUP], Shanni Li[SUP] 1 [/SUP], Youwen Deng[SUP] 4 [/SUP], Jian Peng[SUP] 7 [/SUP], Shuyan Dai[SUP] 8 [/SUP], Xu Deng[SUP] 8 [/SUP], Xianwen Zhang[SUP] 9 [/SUP], Taijiao Jiang[SUP] 10 [/SUP], Zheng Zhang[SUP] 2 [/SUP], Gong Cheng[SUP] 9 11 [/SUP], Jincun Zhao[SUP] 2 10 12 [/SUP], Zanxian Xia[SUP] 13 14 [/SUP]



Affiliations
Abstract

The ORF9b protein, derived from the nucleocapsid's open-reading frame in both SARS-CoV and SARS-CoV-2, serves as an accessory protein crucial for viral immune evasion by inhibiting the innate immune response. Despite its significance, the precise regulatory mechanisms underlying its function remain elusive. In the present study, we unveil that the ORF9b protein of SARS-CoV-2, including emerging mutant strains like Delta and Omicron, can undergo ubiquitination at the K67 site and subsequent degradation via the proteasome pathway, despite certain mutations present among these strains. Moreover, our investigation further uncovers the pivotal role of the translocase of the outer mitochondrial membrane 70 (TOM70) as a substrate receptor, bridging ORF9b with heat shock protein 90 alpha (HSP90α) and Cullin 5 (CUL5) to form a complex. Within this complex, CUL5 triggers the ubiquitination and degradation of ORF9b, acting as a host antiviral factor, while HSP90α functions to stabilize it. Notably, treatment with HSP90 inhibitors such as GA or 17-AAG accelerates the degradation of ORF9b, leading to a pronounced inhibition of SARS-CoV-2 replication. Single-cell sequencing data revealed an up-regulation of HSP90α in lung epithelial cells from COVID-19 patients, suggesting a potential mechanism by which SARS-CoV-2 may exploit HSP90α to evade the host immunity. Our study identifies the CUL5-TOM70-HSP90α complex as a critical regulator of ORF9b protein stability, shedding light on the intricate host-virus immune response dynamics and offering promising avenues for drug development against SARS-CoV-2 in clinical settings.


 
Back
Top Bottom